Insights/Case studies/Newsroom/CareersCareersCareersPartnersConsultantsTechnology innovationCorporateEarly careersSearch Jobs/About us/Contact us Global locations

  • Phone
  • Contact us
  • Locations
  • Search
  • Menu


  • Add this article to your LinkedIn page
  • Add this article to your Twitter feed
  • Email this article
View or print a PDF of this page

Electronic Records: Beneficial to All, But at a Price and Preparing for the EHR Environment

Robin Robinson
1 May 2010

Chris Steel, leader of PA's Healthcare IT Working Group in the US, was quoted in the May issue of PharmaVoice, in two articles covering electronic medical records. 

In the first article, Chris comments on the benefits, such as better trial data and better measurement of drug safety and efficacy, and challenges, i.e. cost and speed to market, that pharmaceutical companies may face from a systemswide, interoperable electronic records system.  According to Chris, "EHR (electronic health records)...will support the collation and analysis of data which show the efficacy of different therapies within different patient populations, supporting a more targeted response.  Whether this is a benefit or a risk to pharmaceutical companies depends on how early and how effectively they engage as a key player in shaping the change."

In the second article, which covered what the next phase of EMR adoption will mean to the pharmaceutical industry, Chris comments that "pharma will have to get much more closely involved in working with payers and providers to understand what treatment approaches they would like to be able to use over the next five years.  This will not replace the current push model of drug development which starts with finding the molecule but complements it with a more patient oriented pull model which might, for example, result in known molecules being delivered as part of different treatment approaches through different devices in different formulations."

To read these two articles, please visit here and turn to pages 12 and 22, respectively.

To visit PA's Heathcare pages, click here.


Sign-up to receive company updates and press releases by email or newsfeed:



Corporate headquarters
10 Bressenden Place
London SW1E 5DN London SW1E 5DN
United Kingdom
Tel: +44 20 7333 5865 Tel: +44 20 7333 5865
contact us now

By using this website, you accept the use of cookies. For more information on how to manage cookies, please read our privacy policy.